Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

JOURNAL ARTICLE

REVIEW

Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

Barbara S Wiggins, Joseph J Saseen, Robert L Page, Brent N Reed, Kevin Sneed, John B Kostis, David Lanfear, Salim Virani, Pamela B Morris

Circulation 2016 November 22, 134 (21): e468-e495

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

You are not logged in. Sign Up or Log In to join the discussion.

Effect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin. Lloyd R Whitfield, Anthony R Porcari, Christine Alvey, Robert Abel, William Bullen, Daniel Hartman Journal of Clinical Pharmacology 2011, 51 (3): 378-88

Gemfibrozil in Combination with Statins-Is It Really Contraindicated? Barbara S Wiggins, Joseph J Saseen, Pamela B Morris Current Atherosclerosis Reports 2016, 18 (4): 18

Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. Peter H Jones, Michael H Davidson American Journal of Cardiology 2005 January 1, 95 (1): 120-2

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Neil J Stone, Jennifer G Robinson, Alice H Lichtenstein, C Noel Bairey Merz, Conrad B Blum, Robert H Eckel, Anne C Goldberg, David Gordon, Daniel Levy, Donald M Lloyd-Jones, Patrick McBride, J Sanford Schwartz, Susan T Shero, Sidney C Smith, Karol Watson, Peter W F Wilson, Karen M Eddleman, Nicole M Jarrett, Ken LaBresh, Lev Nevo, Janusz Wnek, Jeffrey L Anderson, Jonathan L Halperin, Nancy M Albert, Biykem Bozkurt, Ralph G Brindis, Lesley H Curtis, David DeMets, Judith S Hochman, Richard J Kovacs, E Magnus Ohman, Susan J Pressler, Frank W Sellke, Win-Kuang Shen, Sidney C Smith, Gordon F Tomaselli Circulation 2014 June 24, 129 (25 Suppl 2): S1-45

Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans. Arthur J Bergman, Gail Murphy, Joanne Burke, Jamie J Zhao, Robert Valesky, Lida Liu, Kenneth C Lasseter, Weili He, Thomayant Prueksaritanont, Yue Qiu, Alan Hartford, Jose M Vega, John F Paolini Journal of Clinical Pharmacology 2004, 44 (9): 1054-62

Fenofibric acid for hyperlipidemia. Alok Saurav, Manu Kaushik, Syed M Mohiuddin Expert Opinion on Pharmacotherapy 2012, 13 (5): 717-22

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. David Williams, John Feely Clinical Pharmacokinetics 2002, 41 (5): 343-70

Make the most of Read.
Download the mobile app.

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Read